Karla V. Ballman

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Karla V. Ballman

Nov 14, 2024, 08:55 | Blog

Gustavo Viani: Pembrolizumab as a novel systemic therapy option for stage III undifferentiated pleomorphic sarcoma

Gustavo Viani, Associate Professor in the Department of Medical Imaging, Hematology, and Oncology at Hospital…

Sep 24, 2024, 12:30 | Societies

11 ESMO24 presentations published on NEJM

At the 2024 ESMO Congress, 11 articles were presented that were published in NEJM, highlighting…

Sep 19, 2024, 16:49 | Insight

Elad Sharon: Proud to be part of the team that brought together the AMBASSADOR trial

Elad Sharon, Medical Oncologist at Dana-Farber, shared his recent article on X: "Incidentally, this is…

May 1, 2024, 17:21 | Drugs

Piotr Wysocki: Adjuvant aspirin failed to improve outcomes of breast cancer patients

Piotr Wysocki recently shared on LinkedIn: "A large, phase III trial (Alliance A011502) enrolled 3020…

All: 4 Posts: 1 - 100

'

April is Head and Neck Cancer Awareness Month

'

Is Cancer Hereditary? Myths and Facts about Cancer Genetics

'

Neuroendocrine Lung Tumors: Types, Symptoms, Diagnosis, Treatment and 2025 updates

'

Cancer Center Near Me: Dana-Farber Cancer Institute

'

FDA Approves Nivolumab and Ipilimumab for First-Line Treatment of Unresectable Hepatocellular Carcinoma Based on CheckMate-9DW Trial

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023